vimarsana.com

Page 181 - வர்த்தகம் தொடர்புடையது அம்சங்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

US Senators Urge Pfizer, Other American Vaccine Manufacturers to Share Technology With India

To improve the performance of our website, show the most relevant news products and targeted advertising, we collect technical impersonal information about you, including through the tools of our partners. You can find a detailed description of how we use your data in our Privacy Policy. For a detailed description of the technologies, please see the Cookie and Automatic Logging Policy. By clicking on the Accept & Close button, you provide your explicit consent to the processing of your data to achieve the above goal. You can withdraw your consent using the method specified in the Privacy Policy. Accept & Close Sputnik International

Hope Biden tells Pfizer to allow India develop its vaccines, says US Congressman

Hope Biden tells Pfizer to allow India develop its vaccines, says US Congressman Allow India to develop that vaccine, and this is good in your own long-term interests. It s good for the United States and our interests with the role with India and the rest of the world, Ro Khanna told the media PTI | April 28, 2021 | Updated 08:02 IST With millions of lives at stake amid a rapid spread of COVID-19, Indian-American Congressman Ro Khanna said he hoped President Joe Biden would call the Pfizer CEO to let India produce its vaccine at least for six months or a year. Khanna, who represents Silicon Valley in the US House of Representatives, has been an ardent supporter of the move by India and South Africa at the World Trade Organization (WTO) for Trade-Related Aspects of Intellectual Property Rights (TRIPS) waiver of COVID-19 vaccines.

Top U S trade negotiator discusses vaccine ramp-up with

White House Weighs Whether To Back Open Vaccine Push Opposed By Bill Gates, Big Pharma

by Tyler Durden Tuesday, Apr 27, 2021 - 11:20 PM As the latest wave of India s COVID-19 outbreak metastasizes into a full-blown crisis, India and other developing economies are seizing the opportunity to push back against the Bill Gates-backed status quo that prioritizes the intellectual property rights of big pharma over access to plentiful and cheap vaccines in the developing world. Gates has continued to insist that the current approach is the best option for the developing world. But increasingly, it seems the governments of India, South Africa, Nigeria and other emerging powers disagree. And as a showdown looms at the WTO, Washington is being pressed to confront the obvious hypocrisy in backing Gates over the open vaccine movement.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.